Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis

H von Bibra1, M St John Sutton

  • 1Clinic for Endocrinology, Diabetes and Vascular Medicine, Klinikum Bogenhausen, Städt. Klinikum München GmbH, Englschalkingerstrasse 77, 81925 Munich, Germany. von-Bibra@extern.lrz-muenchen.de

Diabetologia
|March 30, 2010
PubMed

Insights

Diastolic dysfunction is common in diabetes and metabolic syndrome, impacting heart function. New imaging techniques help quantify this, revealing links to metabolic health and potential therapeutic targets.

Area of Science:

  • Cardiology
  • Metabolic Diseases
  • Medical Imaging

Background:

  • Cardiac disease in diabetes mellitus and metabolic syndrome involves vascular and myocardial issues, primarily diastolic dysfunction.
  • Evaluating diastolic dysfunction is challenging due to limitations of traditional Doppler echocardiography.
  • New imaging technologies offer detailed quantification of diastolic function.

Purpose of the Study:

  • To highlight the prevalence and evaluation challenges of diastolic dysfunction in diabetes and metabolic syndrome.
  • To discuss the role of advanced imaging techniques like tissue Doppler imaging and cine magnetic resonance imaging (CMR).
  • To explore the relationship between cardiovascular risk factors, myocardial bioenergetics, and diastolic dysfunction.

Main Methods:

  • Utilizing tissue Doppler imaging for quantifying subclinical diastolic dysfunction in clinical practice.
  • Employing cine magnetic resonance imaging (CMR) as a research tool for molecular mechanisms.
  • Analyzing the linear decline of diastolic function with age in normal individuals.

Main Results:

  • Diastolic dysfunction in diabetes and metabolic syndrome is influenced by cardiovascular risk factors affecting myocardial stiffness and energy metabolism.
  • Improvements in diastolic function correlate with better metabolic control through therapy or lifestyle changes.
  • Diastolic dysfunction reflects the myocardial structural and metabolic state.

Conclusions:

  • Diastolic dysfunction is a key indicator of cardiac issues in diabetes and metabolic syndrome.
  • Advanced imaging techniques are crucial for accurate assessment and research.
  • Targeting myocardial metabolism offers potential therapeutic strategies to prevent heart failure in insulin resistance and diabetes.

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...